News|Articles|July 9, 2024

Accelerate time to market with integrated CRO/CDMO services

Author(s)Patheon

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

BySCIEX

November 10th 2025

Improving end-to-end metabolite identification by LC-MS/MS

BySCIEX

November 10th 2025

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

BySCIEX

November 10th 2025

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

BySCIEX

November 10th 2025

Targeted high resolution metabolite screening workflows

BySCIEX

November 10th 2025

Accelerate time to market with integrated CRO/CDMO services

Newsletter

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

Improving end-to-end metabolite identification by LC-MS/MS

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

Targeted high resolution metabolite screening workflows

Trending on Pharmaceutical Technology

How 3D-Printed Tablets Can Optimize IgA Nephropathy Treatment

BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership

Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation